Skip to content
Wednesday, February 04, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • In moments of crisis, Jewish National Fund-USA is there February 4, 2026
  • My Adventure Of A Lifetime February 4, 2026
  • Israeli-Palestinian restaurant shutters in Berlin, though a TV show will continue its story February 4, 2026
  • HIAS shuts Vienna office that aided generations of refugees after Trump pulls funding February 3, 2026
  • I traveled from Israel to Spain to convert new Jews. A single ‘Sababa’ made me feel safer. February 3, 2026
  • A Gen Z student activist against antisemitism is running for State Assembly on Long Island February 3, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.